Cost-description and multiple imputation of missing values: theSATisfaction and adherence to COPD treatment(SAT) study-Reference-Cited by-同舟云学术

Cost-description and multiple imputation of missing values: theSATisfaction and adherence to COPD treatment(SAT) study

Published:2018-01 Issue: Volume:2018 Page:228424031878887
ISSN:2284-2403
Container-title:Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
language:en
Short-container-title:Global & Regional Health Technology Assessment

Author:

Lazzaro Carlo¹^ORCID,Di Marco Fabiano²,Scichilone Nicola³,Braido Fulvio⁴,Contoli Marco⁵,Rogliani Paola⁶,Santus Pierachille⁷,Acciai Valentina⁸,Scognamillo Carla⁸,Olivi Irene⁸,Corsico Angelo Guido⁹

Affiliation:

1. Studio di Economia Sanitaria, Milano, Italia

2. Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italia

3. Dipartimento di Medicina, Pneumologia, Fisiologia e Nutrizione Umana Università degli Studi di Palermo, Palermo, Italia

4. Dipartimento Medicina Interna, Clinica di Malattie dell’Apparato Respiratorio e Allergologia - Ospedale S. Martino, Genova, Italia

5. Pneumologia Azienda Universitaria-Ospedaliera, Ferrara, Italia

6. Dipartimento di Medicina Sperimentale e Chirurgia Università di Roma “Tor Vergata”, Roma, Italia

7. Dipartimento di Scienze Biomediche e Cliniche ‘L. Sacco’ (DIBIC), Università degli Studi di Milano, Milano, Italia

8. Boehringer-Ingelheim S.p.A, Milano, Italia

9. Struttura Complessa Pneumologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italia

Publisher

Aboutscience Srl

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/2284240318788877

Reference50 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

2. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study

3. Healthcare costs of COPD in Italian referral centres: A prospective study

4. The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients